BLOOD BANKS' AUTOMATED TEST SYSTEMS FOR INFECTIOUS DISEASES SHOULD BE CONSIDERED CLASS II, BPAC RECOMMENDS; OTHER BLOOD COLLECTION DEVICES RECLASSIFIED
This article was originally published in The Gray Sheet
Automated test systems used by blood banks for infectious disease screening should be regulated as Class II devices, FDA's Blood Products Advisory Committee recommended at a June 19 meeting in Rockville, Maryland.
You may also be interested in...
With Brexit less than a month old, Germany’s medtech industry has renewed its push for an MRA between the EU and UK in medtech regulation.
Days after a senior Chinese government official offered free COVID-19 vaccines to the Philippines government, the country’s medicines regulator said the donated jabs would need an emergency approval before they can be used on the public.
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.